anti-CXCR3 antibody (Pfizer/Seoul National University)

N/A

Report date: 2025/03/14 16:55:35

Base Information

Drug Nameanti-CXCR3 antibody (Pfizer/Seoul National University)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionC-X-C motif chemokine receptor 3 antagonists
TargetsC-X-C motif chemokine receptor 3
Therapy Area/IndicationsMyositis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncSeoul National University
Inactive CompaniesN/A
Active IndicationsMyositis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A